These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 23642060)

  • 21. DNA methylation dynamics in human induced pluripotent stem cells.
    Nishino K; Umezawa A
    Hum Cell; 2016 Jul; 29(3):97-100. PubMed ID: 27083573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Breakthrough in research on pluripotent stem cells and their application in medicine].
    Valdimarsdóttir G; Richter A
    Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
    Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
    Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Challenge of Bringing iPSCs to the Patient.
    Ortuño-Costela MDC; Cerrada V; García-López M; Gallardo ME
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
    Jozefczuk J; Prigione A; Chavez L; Adjaye J
    Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of human organs in pigs via interspecies blastocyst complementation.
    Wu J; Platero Luengo A; Gil MA; Suzuki K; Cuello C; Morales Valencia M; Parrilla I; Martinez CA; Nohalez A; Roca J; Martinez EA; Izpisua Belmonte JC
    Reprod Domest Anim; 2016 Oct; 51 Suppl 2():18-24. PubMed ID: 27762052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
    Rezanejad H; Matin MM
    Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine.
    Kingham E; Oreffo RO
    ACS Nano; 2013 Mar; 7(3):1867-81. PubMed ID: 23414366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
    Yoshida Y; Yamanaka S
    Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced pluripotent stem cells for cardiac repair.
    Zwi-Dantsis L; Gepstein L
    Cell Mol Life Sci; 2012 Oct; 69(19):3285-99. PubMed ID: 22960788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. iPSCs, aging and age-related diseases.
    Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
    N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Embryonic stem cells from blastomeres maintaining embryo viability.
    Klimanskaya I
    Semin Reprod Med; 2013 Jan; 31(1):49-55. PubMed ID: 23329636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent technological updates and clinical applications of induced pluripotent stem cells.
    Diecke S; Jung SM; Lee J; Ju JH
    Korean J Intern Med; 2014 Sep; 29(5):547-57. PubMed ID: 25228828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human kidney cell reprogramming: applications for disease modeling and personalized medicine.
    O'Neill AC; Ricardo SD
    J Am Soc Nephrol; 2013 Sep; 24(9):1347-56. PubMed ID: 23949797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature review.
    Ali EAM; Smaida R; Meyer M; Ou W; Li Z; Han Z; Benkirane-Jessel N; Gottenberg JE; Hua G
    Stem Cell Res Ther; 2024 Jun; 15(1):185. PubMed ID: 38926793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.